a b s t r a c t
Background: Although deep brain stimulation of the subthalamic nucleus (STN DBS) in Parkinson disease (PD) improves motor function, it has variable effects on working memory (WM) and response inhibition (RI) performance. The purpose of this study was to determine the neural correlates of STN DBS-induced variability in cognitive performance. Methods: We measured bilateral STN DBS-induced blood flow changes (PET and [ 15 O]-water on one day) in the supplementary motor area (SMA), dorsolateral prefrontal cortex (DLPFC), anterior cingulate cortex (ACC), and right inferior frontal cortex (rIFC) as well as in exploratory ROIs defined by published metaanalyses. STN DBS-induced WM and RI changes (Spatial Delayed Response and Go-No-Go on the next day) were measured in 24 PD participants. On both days, participants withheld PD medications overnight and conditions (OFF vs. ON) were administered in a counterbalanced, double-blind manner. Results: As predicted, STN DBS-induced DLPFC blood flow change correlated with change in WM, but not RI performance. Furthermore, ACC blood flow change correlated with change in RI but not WM performance. For both relationships, increased blood flow related to decreased cognitive performance in response to STN DBS. Of the exploratory regions, only blood flow changes in DLPFC and ACC were correlated with performance.
Conclusions: These results demonstrate that variability in the effects of STN DBS on cognitive performance relates to STN DBS-induced cortical blood flow changes in DLPFC and ACC. This relationship highlights the need to further understand the factors that mediate the variability in neural and cognitive response to STN DBS. © 2008 Elsevier Ltd. All rights reserved.
Deep brain stimulation of the subthalamic nucleus (STN DBS) provides effective treatment of the motor symptoms for many individuals with Parkinson disease (PD) (Limousin et al., 1995).
However, recent work suggests that STN DBS has a more variable effect on cognitive functioning (Voon, Kubu, Krack, Houeto, & Troster, 2006) and may even negatively affect select cognitive processes, especially cognitive control (Temel, Blokland, Steinbusch, & Visser-Vandewalle, 2005) . In fact, a recent review of the literature revealed that approximately 41% of individuals with STN DBS experience cognitive problems (Temel et al., 2006) . Cogni-tive dysfunction in non-demented individuals with PD is common (30-70%) (Green et al., 2002) ; can significantly decrease perceived quality of life (Schrag, Jahanshahi, & Quinn, 2000) ; can impair functional ability in work and home environments (Weintraub, Moberg, Duda, Katz, & Stern, 2004) ; and is a relatively common effect of STN DBS (Temel et al., 2006) . To further optimize this therapeutic technique, it is important to determine the mechanisms that produce the variability in cognitive effects of STN DBS. This information may also provide new insights into basal ganglia-thalamocortical pathway involvement in cognitive control.
Although the role of the prefrontal cortex (PFC) in cognitive control processes has been emphasized, the STN also may contribute to cognitive control systems (Baunez et al., 2001; Chudasama, Baunez, & Robbins, 2003; Nakano, Kayahara, Tsutsumi, & Ushiro, 2000) through its connections to the PFC (Alexander, Crutcher, & DeLong, 1990; Alexander, DeLong, & Strick, 1986 
